Details of the Drug Formulations

General Information of Drug (ID: DMOH8VY)

Drug Name
Dacomitinib Drug Info
Synonyms PF-00299804
Indication
Disease Entry ICD 11 Status REF
Non-small-cell lung cancer 2C25.Y Approved [1]
Cross-matching ID
PubChem CID
11511120
ChEBI ID
CHEBI:91466
CAS Number
1110813-31-4
TTD ID
D06XXH
VARIDT ID
DR00109
INTEDE ID
DR0407
ACDINA ID
D00982

Full List of Drug Formulations Containing This Drug

Dacomitinib 15 mg tablet
Company Formulation ID FDA Description
Pfizer Laboratories Div Pfizer F24039 Lactose Monohydrate; Microcrystalline Cellulose; Sodium Starch Glycolate; Magnesium Stearate; Polyvinyl Alcohol Partially Hydrolyzed; Talc; Titanium Dioxide; Macrogol/Peg 3350; Fd&C Blue 2/Indigo Carmine Aluminum Lake
------------------------------------------------------------------------------------
Dacomitinib 30 mg tablet
Company Formulation ID FDA Description
Pfizer Laboratories Div Pfizer F24040 Lactose Monohydrate; Microcrystalline Cellulose; Sodium Starch Glycolate; Magnesium Stearate; Polyvinyl Alcohol Partially Hydrolyzed; Talc; Titanium Dioxide; Macrogol/Peg 3350; Fd&C Blue 2/Indigo Carmine Aluminum Lake
------------------------------------------------------------------------------------
Dacomitinib 45 mg tablet
Company Formulation ID FDA Description
Pfizer Laboratories Div Pfizer F24041 Lactose Monohydrate; Microcrystalline Cellulose; Sodium Starch Glycolate; Magnesium Stearate; Polyvinyl Alcohol Partially Hydrolyzed; Talc; Titanium Dioxide; Macrogol/Peg 3350; Fd&C Blue 2/Indigo Carmine Aluminum Lake
------------------------------------------------------------------------------------

References

1 2018 FDA drug approvals.Nat Rev Drug Discov. 2019 Feb;18(2):85-89.